Howard Xin, JD, MBA, is currently the Executive Director of Securities Corporate Counsel at Spyre Therapeutics, where they focus on corporate law at the intersections of finance and mergers and acquisitions. Previously, Howard held positions as an Associate Lawyer at Blake, Cassels & Graydon LLP and Gowling WLG, and as an Associate Attorney at Gibson, Dunn & Crutcher LLP. Howard's legal journey includes earlier experience as a Summer Law Student at Griffiths Law Offices and a Summer Intern at AIG, along with consulting work at CGI. They completed their J.D./M.B.A. at York University and hold a Bachelor of Commerce degree with a specialization in Finance and Economics from the University of Toronto.
This person is not in any teams
This person is not in any offices